×
验证码:
换一张
Forgotten Password?
Stay signed in
Login With UMPASS
English
|
繁體
Login With UMPASS
Log In
ALL
ORCID
TI
AU
PY
SU
KW
TY
JN
DA
IN
PB
FP
ST
SM
Study Hall
Image search
Paste the image URL
Home
Faculties & Institutes
Scholars
Publications
Subjects
Statistics
News
Search in the results
Faculties & Institutes
Institute of Chi... [4]
Faculty of Healt... [3]
THE STATE KEY LA... [2]
INSTITUTE OF COL... [2]
SHIU PONG COLLEG... [1]
Authors
WANG YITAO [4]
LU JINJIAN [2]
CHEN XIUPING [2]
WANG CHUNMING [1]
LI PENG [1]
CHEN MEIWAN [1]
More...
Document Type
Journal article [6]
Date Issued
2023 [2]
2014 [1]
2013 [2]
2012 [1]
Language
英語English [4]
Source Publication
Expert Opinion o... [4]
EXPERT OPINION O... [2]
Indexed By
SCIE [5]
Funding Organization
Funding Project
×
Knowledge Map
UM
Start a Submission
Submissions
Unclaimed
Claimed
Attach Fulltext
Bookmarks
Browse/Search Results:
1-6 of 6
Help
Selected(
0
)
Clear
Items/Page:
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
95
100
Sort:
Select
Issue Date Ascending
Issue Date Descending
Journal Impact Factor Ascending
Journal Impact Factor Descending
WOS Cited Times Ascending
WOS Cited Times Descending
Submit date Ascending
Submit date Descending
Title Ascending
Title Descending
Author Ascending
Author Descending
Multiple initiatives to conquer KRAS G12C inhibitor resistance from the perspective of clinical therapy
Journal article
Zhang JunMin, Zhang JuanHong, Leung Elaine Lai Han, Yao XiaoJun. Multiple initiatives to conquer KRAS G12C inhibitor resistance from the perspective of clinical therapy[J]. EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2023, 32(2), 101-106.
Authors:
Zhang JunMin
;
Zhang JuanHong
;
Leung Elaine Lai Han
;
Yao XiaoJun
Favorite
|
TC[WOS]:
2
TC[Scopus]:
2
IF:
4.9
/
5.3
|
Submit date:2023/06/15
Kras G12c
Amg 510
Mrtx 849
Targeted Therapy
Drug Resistance
Multiple initiatives to conquer KRAS G12C inhibitor resistance from the perspective of clinical therapy.
Journal article
Zhang JunMin, Zhang JuanHong, Leung Elaine Lai Han, Yao XiaoJun. Multiple initiatives to conquer KRAS G12C inhibitor resistance from the perspective of clinical therapy.[J]. Expert Opinion on Investigational Drugs, 2023.
Authors:
Zhang JunMin
;
Zhang JuanHong
;
Leung Elaine Lai Han
;
Yao XiaoJun
Favorite
|
IF:
4.9
/
5.3
|
Submit date:2023/10/23
Saponins of Panax notoginseng: Chemistry, cellular targets and therapeutic opportunities in cardiovascular diseases
Journal article
Liu, Jingjing, Wang, Yitao, Qiu, Lan, Yu, Yuanyuan, Wang, Chunming. Saponins of Panax notoginseng: Chemistry, cellular targets and therapeutic opportunities in cardiovascular diseases[J]. Expert Opinion on Investigational Drugs, 2014, 23(4), 523-539.
Authors:
Liu, Jingjing
;
Wang, Yitao
;
Qiu, Lan
;
Yu, Yuanyuan
;
Wang, Chunming
Favorite
|
TC[WOS]:
99
TC[Scopus]:
104
IF:
4.9
/
5.3
|
Submit date:2022/03/18
Cardiovascular Diseases
Natural Drug Discovery
Panax Notoginseng
Saponins
Vascular Pharmacology
Anti-cancer properties of triterpenoids isolated from Ganoderma lucidum - a review
Journal article
Guo-Sheng Wu, Jia-Jie Guo, Jiao-Lin Bao, Xi-Wen Li, Xiu-Ping Chen, Jin-Jian Lu, Yi-Tao Wang. Anti-cancer properties of triterpenoids isolated from Ganoderma lucidum - a review[J]. Expert Opinion on Investigational Drugs, 2013, 22(8), 981-992.
Authors:
Guo-Sheng Wu
;
Jia-Jie Guo
;
Jiao-Lin Bao
;
Xi-Wen Li
;
Xiu-Ping Chen
; et al.
Favorite
|
TC[WOS]:
108
TC[Scopus]:
124
IF:
4.9
/
5.3
|
Submit date:2019/01/07
Cancer
Ganoderma Lucidum
Traditional Chinese Medicine
Triterpenoids
Analysis of Pogostemon cablin from pharmaceutical research to market performances
Journal article
Chen MW, Zhang JM, Lai YF, Wang SP, Li P, Xiao J, Fu CM, Hu H, Wang YT. Analysis of Pogostemon cablin from pharmaceutical research to market performances[J]. Expert Opinion on Investigational Drugs, 2013, 22(2), 245-257.
Authors:
Chen MW
;
Zhang JM
;
Lai YF
;
Wang SP
;
Li P
; et al.
Favorite
|
TC[WOS]:
32
TC[Scopus]:
39
IF:
4.9
/
5.3
|
Submit date:2018/11/28
Chemical Composition
Market Performances
Pharmacological Effect
Pogostemon Cablin
Quality Evaluation
Terpenoids: natural products for cancer therapy
Journal article
Huang, Min, Lu, Jin-Jian, Huang, Ming-Qing, Bao, Jiao-Lin, Chen, Xiu-Ping, Wang, Yi-Tao. Terpenoids: natural products for cancer therapy[J]. EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2012, 21(12), 1801-1818.
Authors:
Huang, Min
;
Lu, Jin-Jian
;
Huang, Ming-Qing
;
Bao, Jiao-Lin
;
Chen, Xiu-Ping
; et al.
Favorite
|
TC[WOS]:
227
TC[Scopus]:
260
IF:
4.9
/
5.3
|
Submit date:2018/11/01
Nf-kappa-b
Cells In-vitro
Human Breast-cancer
Pseudolaric-acid-b
Dihydroartemisinin Induces Apoptosis
Fibrosarcoma L929 Cells
Hypoxia-inducible Factor-1-alpha
Hepatocellular-carcinoma Cells
Lycopene Inhibits Angiogenesis
Oridonin-induced Apoptosis